rs9545424
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001330071.2(DCLK1):c.1689-32C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 1,572,050 control chromosomes in the GnomAD database, including 12,821 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1050 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11771 hom. )
Consequence
DCLK1
NM_001330071.2 intron
NM_001330071.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0620
Publications
11 publications found
Genes affected
DCLK1 (HGNC:2700): (doublecortin like kinase 1) This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. The encoded protein is involved in several different cellular processes, including neuronal migration, retrograde transport, neuronal apoptosis and neurogenesis. This gene is up-regulated by brain-derived neurotrophic factor and associated with memory and general cognitive abilities. Multiple transcript variants generated by two alternative promoter usage and alternative splicing have been reported, but the full-length nature and biological validity of some variants have not been defined. These variants encode different isoforms, which are differentially expressed and have different kinase activities.[provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.168 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DCLK1 | ENST00000360631.8 | c.1689-32C>T | intron_variant | Intron 12 of 16 | 5 | NM_001330071.2 | ENSP00000353846.3 | |||
| DCLK1 | ENST00000255448.8 | c.1689-32C>T | intron_variant | Intron 12 of 17 | 1 | ENSP00000255448.4 | ||||
| DCLK1 | ENST00000379893.5 | c.768-32C>T | intron_variant | Intron 8 of 12 | 2 | ENSP00000369223.1 | ||||
| DCLK1 | ENST00000615680.5 | c.768-32C>T | intron_variant | Intron 8 of 13 | 2 | ENSP00000484452.1 |
Frequencies
GnomAD3 genomes AF: 0.109 AC: 16623AN: 151958Hom.: 1048 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16623
AN:
151958
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.120 AC: 29224AN: 243024 AF XY: 0.124 show subpopulations
GnomAD2 exomes
AF:
AC:
29224
AN:
243024
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.125 AC: 177382AN: 1419972Hom.: 11771 Cov.: 24 AF XY: 0.125 AC XY: 88497AN XY: 706058 show subpopulations
GnomAD4 exome
AF:
AC:
177382
AN:
1419972
Hom.:
Cov.:
24
AF XY:
AC XY:
88497
AN XY:
706058
show subpopulations
African (AFR)
AF:
AC:
2178
AN:
32676
American (AMR)
AF:
AC:
2716
AN:
43672
Ashkenazi Jewish (ASJ)
AF:
AC:
4928
AN:
25206
East Asian (EAS)
AF:
AC:
6440
AN:
38966
South Asian (SAS)
AF:
AC:
10083
AN:
82048
European-Finnish (FIN)
AF:
AC:
4850
AN:
52474
Middle Eastern (MID)
AF:
AC:
859
AN:
5600
European-Non Finnish (NFE)
AF:
AC:
137714
AN:
1080886
Other (OTH)
AF:
AC:
7614
AN:
58444
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
7432
14864
22296
29728
37160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5048
10096
15144
20192
25240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.109 AC: 16627AN: 152078Hom.: 1050 Cov.: 32 AF XY: 0.107 AC XY: 7977AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
16627
AN:
152078
Hom.:
Cov.:
32
AF XY:
AC XY:
7977
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
2872
AN:
41480
American (AMR)
AF:
AC:
1431
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
687
AN:
3470
East Asian (EAS)
AF:
AC:
918
AN:
5174
South Asian (SAS)
AF:
AC:
568
AN:
4814
European-Finnish (FIN)
AF:
AC:
971
AN:
10582
Middle Eastern (MID)
AF:
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8835
AN:
67986
Other (OTH)
AF:
AC:
251
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
741
1481
2222
2962
3703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
526
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.